论文部分内容阅读
目的前瞻性对照一体化PET/CT和3.0 T全身MRI确定非小细胞肺癌(NSCLC)TMN分期的诊断效用。方法本研究经伦理委员会批准,所有受试者均签署知情同意书。本研究包括了病理证实的165例NSCLC病人(男125例,
Objective To prospectively validate the diagnostic utility of TMN staging of non-small cell lung cancer (NSCLC) using integrated PET / CT and 3.0 T whole body MRI. Methods The study was approved by Ethics Committee and all participants signed informed consent form. This study included 165 pathologically confirmed NSCLC patients (125 males,